Abstract:Background: Numerous studies have demonstrated that iron overload is a risk factor of osteoporosis. However, there has been no systematic and in-depth studies on the effect of iron overload on osteocytes and its role in iron overload-induced bone loss. Therefore, to address this problem, we carried out in vitro and in vivo studies using MLO-Y4 osteocyte-like cells and Hepcidin(-/-) mice as iron overload models. Methods: (1) MLO-Y4 cells were treated with ferric ammonium citrate (FAC). Intracellular reactive oxygen species (ROS) levels and apoptosis of MLO-Y4 cells were determined by flow cytometry. Western blotting was performed to evaluate the effect of FAC on the expression of sclerostin and RANKL/OPG. (2) The conditioned medium of MLO-Y4 cells after treatment with FAC was collected and used to treat pre-osteoblasts and monocytes. Alkaline phosphatase (ALP) staining and alizarin red (AR) staining were used to evaluate osteogenic differentiation capacity, and tartrate-resistant acid phosphatase (TRAP) staining was performed to demonstrate osteoclast differentiation capacity. (3) In vivo studies included a wild type mouse, Hepcidin(-/-) mice, Hepcidin(-/-) mice + deferoxamine (DFO), and Hepcidin(-/-) mice + N-actyl-L-cysteine (NAC) group. Micro-CT was performed to evaluate the bone mineral density (BMD), bone volume, and bone micro-architecture of the mice, and three bending tests were used to assess bone strength. Histological analysis was used to detect alterations in bone turnover. TUNEL staining and scanning electron microscopy (SEM) were performed to evaluate the apoptosis and morphology of osteocytes. Immunohistochemical staining and Western blotting were used to determine alterations in sclerostin and RANKL/OPG expression levels in mice. Results: (1) FAC increased intracellular ROS and apoptosis in MLO-Y4 cells, while FAC enhanced the expression of sclerostin and RANKL/OPG in MLO-Y4 cells. (2) Conditioned medium of MLO-Y4 cells inhibited the osteogenic capacity of osteoblasts while stimulating osteoclast differentiation. (3) By increasing oxidative stress, iron overload promotes the apoptosis of osteocytes and undermines the morphology of osteocytes in Hepcidin(-/-) mice, further increasing the expression levels of sclerostin and RANKL/OPG in osteocytes, which is considered to be the causative factor for reduced bone formation and enhanced bone resorption. DFO administration reduced iron levels, and NAC treatment decreased oxidative stress in Hepcidin(-/-) mice. Therefore, DFO or NAC treatment rescued the decrease in BMD, bone volume, and bone strength and attenuated the deterioration of bone architecture in Hepcidin(-/-) mice by attenuating the effect of iron overload on osteocytes. Conclusion: Osteocyte apoptosis due to increased ROS and resultant sclerostin and RANKL/OPG expression alteration was the main reason for bone loss in Hepcidin(-/-) mice. Osteocytes are the main targets for the prevention and treatment of iron overload-induced osteoporosis.

Effects of iron overload on the bone marrow microenvironment in mice.

Iron Overload Induced Osteocytes Apoptosis and Led to Bone Loss in Hepcidin−/− Mice Through Increasing Sclerostin and RANKL/OPG

Iron Overload Impairs Normal Hematopoietic Stem and Progenitor Cells Through Reactive Oxygen Species and Shortens Survival in Myelodysplastic Syndrome Mice

Heme Oxygenase-1 Protects Bone Marrow Mesenchymal Stem Cells Against Iron Overload Through Decreasing ROS and Promoting IL-10 Generation

Exogenous iron caused osteocyte apoptosis, increased RANKL production, and stimulated bone resorption through oxidative stress in a murine model

Effects of deferoxamine and iron overload on bone mass of male mice

Ros-Mediated Iron Overload Injures The Hematopoiesis Of Bone Marrow By Damaging Hematopoietic Stem/Progenitor Cells In Mice (Vol 5, 10181, 2015)

Effect of Iron Overload on the Bone Turnover Markers of Mice Serum

Iron accumulation induces reactive oxide species to inhibits mesenchymal stem cells and osteogenesis via nicotinamide adenine dinucleotide phosphate reduced oxidase 4 activation

Ionizing Radiation Exacerbates the Bone Loss Induced by Iron Overload in Mice

Effect of iron overload on endothelial cell calcification and its mechanism

Differentiation of intestinal stem cells toward goblet cells under systemic iron overload stress are associated with inhibition of Notch signaling pathway and ferroptosis

Experimental study on the effect of iron accumulation on bonemass, intraosseous vessels and vascular endothelial cells in mice

Iron Accumulation Inhibits the Bone Formation of Ovariectomized Mice Via Stimulating Oxidative Stress

Effect of deferoxamine administration on the treatment of iron accumulation-induced osteopenia in male mice

Iron Overload Affect on Iron Homeostasis and Biological Activity of Osteoblasts

Effects of oxidative stress on inhibition of osteoblasts activity by iron

Iron Overload Inhibits Osteoblast Biological Activity Through Oxidative Stress

Iron overload inhibits osteogenesis and promotes adipogenesis in human bone marrow mesenchymal stem cells by producing reactive oxygen

Impact of Iron Overload in Hematopoietic Stem Cell Transplantation

The Effect of Iron Overload and Chelation on Erythroid Differentiation.